SlideShare a Scribd company logo
Dr Malini
Topics to be covered
1. Indications
2. Technique of biopsy
3. General approach to prostate needle biopsy
4. Normal histology
5. Histologic variations of normal prostatic tissue
6. Histologic features specific for prostate cancer
7. Limited cancer on needle biopsy
8. Benign mimics of prostate cancer
9. IHC
10. Current concepts in gleason score
Indications of prostate biopsy
 Symptoms - frequency
 Increased serum PSA
 Digital Rectal Examination – hard prostate
Biopsy Techniques for Prostate
Cancer Detection
Transrectal and Transperineal Biopsy Approaches
for Prostate Cancer Detection
Biopsy Parameters That Impact Prostate Cancer
Detection Rate in Prostate Needle Biopsy
 Factors related to biopsy procedure and operator
1. Number of cores obtained
2. Laterality of the biopsy procedure (paramedian versus
laterally directed biopsy approach)
3. Transrectal versus transperineal (anterior-based) approach
4. Operator experience and skill
 Factors related to pathology laboratory practice
1. Number of needle cores embedded in cassette (ideal 1–2
core/cassette)
2. Tissue-sectioning protocol and number of levels examined
3. Histotechnologist’s skill
4. Pathologist’s skill and experience
General Approach to Prostate Needle
Biopsy Evaluation
1. Use benign glands as reference and study their low-power
architectural features and high-power cytological features
(cytoplasmic characteristics, nuclear size and morphology, and
nucleolar prominence in secretory and basal cells)
2. Scan biopsy cores to look for glands that appear different from
and do not fit in with benign glands
3. Evaluate the architectural features at low power and
cytological features at high power of atypical glands
4. Cancer diagnosis is made based on hematoxylin–eosin stain
(H&E) examination; use ancillary immunohistochemistry
prudently to support H&E impression
Normal histology of prostate
 Glandular component is composed of acini and ducts,
which is subdivided into large (primary, major, excretory)
and peripheral (secondary, minor)
 Acini & ducts contain secretory cells, basal cells & scattered
neuroendocrine cells
 Secretory cells
 located in the luminal side, contribute to products of seminal fluid,
like Prostatic acid phosphatase (PAP) and Prostate-specific antigen
(PSA)
 Secretory cells also co-express various keratins & vimentin
 Normal secretion is a neutral mucosubstance ( most
adenocarcinomas secrete acidic & neutral mucin)
In this benign gland, the luminal contour shows tufts and papillary infoldings.
The tall secretory epithelial cells have pale clear cytoplasm and uniform round or
oval nuclei.
Prominent nucleoli are not seen. Many basal cells can be identified
 Basal cells
 Form a thin continuous layer that separates secretory
cells from basement membrane
 Cell nuclei are cigar-shaped or resembles fibroblasts &
are oriented parallel to BM
 Inconspicuous in benign glands
 Characteristically contains keratin 34Eβ12, CK8.2, 312
C8-1
 Normally, these cells do not have phenotype of myo-
epithelial cells as they are negative for S-100 or SMA
 Do not express PSA or PAP
This benign gland contains corpora amylacea. Even at low magnification, basal cells can be
clearly seen. Compare this with next slide which highlights the basal cell layer with the
immunostain for high molecular weight cytokeratin 34bE12.
Basal cells are present in a continuous layer in most benign glands. The antibodies to high
molecular weight cytokeratin 34bE12 stain basal cells but not secretory or stromal cells in the
prostate. Besides cancer, the basal cell layer may be disrupted in atrophy, inflammation, atypical
adenomatous hyperplasia (adenosis), and high-grade PIN.
 Neuroendocrine cells
 express chromogranin A & B, secretogranin II, and
hormones like somatostatin & calcitonin
 Co-express PSA suggesting common origin with
secretory cells
Neuroendocrine cells are seen in benign prostate, high-grade PIN, and cancer. They are most
abundant near verumontanum. In this image, many neuroendocrine cells with large eosinophilic
granules (Paneth cell-like change) are seen in atrophic prostate glands
 Large prostatic ducts
 lined by transitional epithelium which is continuous
with & indistinguishable from lining of prostatic urethra
 Do not display umbrella cells, but a single layer of
columnar cells that are PSA & PAP positive
 Prostatic stroma
 Mainly composed of smooth muscle fibres, which
functions to squeeze out prostatic secretions
 Peripheral nerves are evenly distributed in the apex, mid
gland & base
Skeletal muscle fibers of the urogenital diaphragm extend into the apical and anterior
peripheral regions of the prostate. Not infrequently, skeletal muscle fibers are seen in
needle biopsies from those regions
Ganglia found in prostate needle biopsies should not be mistaken for high-grade carcinoma.
Note the intracellular pigment and satellite cells around neurons.
Benign prostatic glands may abut nerves. Occasionally, they may even partially or completely wrap
around a nerve. This should not reflexly lead to the diagnosis of adenocarcinoma with perineural
invasion. The gland in question in this image lacks enlarged nuclei or nucleoli and shows scattered
basal cells.
A. Corpora amylacea are inspissated secretions that may have a lamellated
appearance. Usually they are pink or purple in appearance. Sometimes
they may be golden-brown.
B. This image shows a round eosinophilic corpus amylaceum in an atrophic
gland. Corpora amylacea are more commonly seen in benign glands and
are rare in carcinomas. Over time, they may calcify and form prostatic
calculi.
A B
+-o

;y7
Histologic Variations of Normal
Prostate Tissue
 Atrophy
 Basal cell hyperplasia
 Urothelial metaplasia
 Perineural abutment
 Glands within skeletal muscle fibers
 Irregular prostate–periprostatic interface
Atrophic prostate
Glands retain lobulated architecture.
Cystic dilatation is common. Glands appear dark due to reduced cytoplasm.
Urothelial metaplasia.
A form of basal cell
hyperplasia, urothelial
metaplasia consists of
stratified basal cells with
longitudinal nuclear
grooves arranged
perpendicular to the
basement membrane
Basal cell hyperplasia.
(a). Prostate glands are rimmed with one or several layers of basal cells
(b). Basal cells have scant cytoplasm and round-to-oval
hyperchromatic nuclei. They are positive for basal cell markers such as
p63.
Some basal cells are stratified and have prominent nucleoli and may
be mistaken for HGPIN. Calcification can also be seen.
Perineural abutment.
(a). A benign prostate gland
abuts and loosely encircles a
nerve fiber
(b) Has to be distinguished
from perineural invasion by
prostate cancer. In difficult
cases, immunostains for basal
cells, such as p63, can be used
to confirm the benign nature
of the glands
Prostate glands within skeletal muscle fibers.
Skeletal muscle can be found intraprostatically, usually in the apex and
anterior fibromuscular layer. Prostate glands can be found within the
skeletal muscle fibers; therefore, finding cancer glands within the skeletal
muscle fibers should not be interpreted as extraprostatic extension
Irregular prostate–periprostatic interface.
The prostate does not have a true capsule. Cancer
glands intermixed with fat in needle biopsy can be interpreted as
extraprostatic extension by cancer
Histological Features Considered Specific for and
Diagnostic of Cancer
 Three features have not been reported in benign
glands and are considered specific for prostate cancer:
 Mucinous fibroplasia (collagenous micronodules)
 Glomerulation
 Perineural invasion
 Cancer diagnosis can be rendered when one of the
three features is present in biopsy
 Mucinous fibroplasia
 It is acellular or
hypocellular
hyalinized stroma
within or outside
cancer glands
(arrows), and results
from hyalinization of
extravasated mucin
Glomerulation:
It results from the intraluminal proliferation of cancer cells that
forms balls or tufts within cancer glands, superficially resembling renal
glomeruli
l
Perineural invasion:
It is defined as tight circumferential or near circumferential encircling of
a nerve fiber by cancer glands. It should be distinguished from
perineural abutment by benign glands.
Major features (strongly associated with cancer
and rarely seen in noncancer lesions)
1. Abnormal architectural pattern
 Infiltrative growth pattern
 Large cribriform glands with irregular contour
 Single or cords of atypical cells
 Solid nests with or without comedo necrosis
2. Absence of basal cells
 Can be confirmed by basal cell marker immunohistochemistry
3. Nuclear atypia
 Nuclear enlargement
 Prominent nucleoli
 Hyperchromasia
1: abnormal architectural pattern –infiltrative growth.
•Most characteristic growth pattern for prostate cancer, with cancer
glands situated between and on both sides of the larger and paler benign
glands.
•This growth pattern is indicative of invasion. The cancer glands are
typically small with rigid round lumens as opposed to large benign glands
with undulating luminal borders.
Abnormal architectural pattern – crowded glands.
•Cancer glands are closely packed and more crowded than the adjacent benign
glands, and are often circumscribed without infiltrative pattern.
•This should raise a suspicion for cancer.
•However, such growth pattern may also be seen in adenosis (atypical
adenomatous hyperplasia), which should always be considered and ruled out
before a cancer diagnosis is rendered
Abnormal architectural pattern – haphazardly arranged glands
without accompanying benign glands.
The cancer glands grow in a haphazard fashion and dissect stroma
and muscle bundles without accompanying benign glands
Abnormal architectural
pattern – single or cords of
atypical cells.
Single cancer cells infiltrate
in the stroma. They also
form short cords
Abnormal architectural
pattern – irregular cribriform
structure.
Cancer glands demonstrate
large cribriform architecture
with irregular and infiltrative
borders
Abnormal architectural pattern –solid nests.
Cancer cells form solid nests without discernible lumens
2: absence of basal cells.
a. Cancer glands are devoid of basal cells on H&E
examination
b. Confirmed by immunostain for basal cell marker p63
which is negative
Partial atrophy with patchy basal cells.
(a). Basal cells can be absent in few benign glands also, such as partial
atrophy
(b). Basal cell immunostain for p63 demonstrates focal staining in some
glands and complete absence of staining in other glands
However, glands with and without basal cell lining have identical
cytological features.
Other noncancerous lesions that often demonstrate patchy or absent basal
cells include adenosis and HGPIN
3: Nuclear atypia – nuclear
enlargement.
Using the adjacent benign
glands (right lower of the
image) as reference, the
cancer cells have
significantly enlarged nuclei
3: Nuclear atypia – prominent nucleoli.
(a) Cancer cells have prominent nucleoli
(b) Nucleolar prominence depends on the
several tissue processing factors,
including fixation, tissue section
thickness, and staining protocols.
Alcohol-based fixatives often obscure the
nuclear detail with blurred chromatin
and inconspicuous nucleoli
(c) Whereas Hollandes fixative enhances
nucleoli with visible nucleoli even in
basal cells of benign glands
3: nuclear atypia – hyperchromasia.
Compared to the adjacent benign glands, cancer cells can have
larger hyperchromatic and pleomorphic nuclei (arrows)
Minor features (less strongly associated with
cancer, may also be seen in non cancer lesions)
 Cytoplasm
 Cytoplasmic amphophilia (dark cytoplasm)
 Intraluminal contents
 Amorphous secretion
 Blue mucin
 Crystalloids
 Mitosis and apoptosis
 More common in prostate cancer
 Adjacent high-grade prostatic intraepithelial neoplasia
(HGPIN)
 Cancer often associated with HGPIN
Amphophilic cytoplasm.
• Compared with benign glands with clear cytoplasm, cancer glands often
have amphophilic, or dark, cytoplasm.
• This feature can be appreciated at low scanning power and, together with
the infiltrative growth Pattern
• Often provides the first clue to the presence of cancer in the biopsy.
• The atypical glands with these minor features usually appear significantly
different and therefore stand out from the benign glands
Amorphous intraluminal secretion.
• Cancer glands have eosinophilic amorphous material within their
lumens.
• They are more common in cancer, but can also be found in some
benign lesions
Blue mucin.
• Cancer glands have blue-tinged wisps of mucin, often together with dense
pink secretion, within their lumens.
• They are more common in cancer, but can also be found in some benign
lesions.
Crystalloids.
• Dense eosinophilic crystalloid structures that assume various shapes
such as rhomboid and needle are in the lumens of the cancer glands.
• They are more common in cancer, but can also be found in some benign
lesions
Mitosis and Apoptosis.
A mitotic figure (arrow, a) and
apoptotic bodies (arrows, b) are
found in cancer glands.
Cancer associated with HGPIN.
1. Cancer glands (arrowheads) often intermingle with HGPIN glands
(arrows).
2. The presence of HGPIN should alert pathologists to look for cancer
in the biopsy
Benign Conditions That Cause
Architectural and Cytological Atypia
Benign process Atypical histological features
Inflammation Small, crowded or cribriform glands
Significant nucleoli
Atrophy Haphazard and disorganized
pattern, poorly formed glands,
mild nuclear enlargement, and
small nucleoli
Adenosis (atypical adenomatous
hyperplasia)
Crowded glands
HGPIN with adjacent small focus
of atypical glands
A few atypical glands immediately
adjacent to larger HGPIN
glands (uncertain whether
atypical glands represent micro
invasive cancer or tangential
sectioning and/or outpouching of
HGPIN glands)
Benign prostate glands with exuberant inflammation.
• The epithelial cells exhibit significant cytological atypia, including
nuclear enlargement and small nucleoli.
• Cancer glands, however, can also be associated with inflammation
Simple atrophy.
(a) Glands have lobulated
architecture
(b) Nuclei are slightly enlarged
with small or inconspicuous
nucleoli
Adenosis.
• Circumscribed, lobular collection of glands with variable sizes.
• Some glands are clearly benign with large irregular contour and undulating
luminal borders.
• Smaller glands with rigid lumens are identical to larger benign glands
cytologically
HGPIN with adjacent small focus of atypical
glands (PINATYP).
• A few atypical glands (arrowhead) lie
immediately adjacent to larger HGPIN
glands (arrows) and are negative for
basal cell marker p63 and positive for a
methylacyl-CoA racemase (AMACR)
• Note the HGPIN glands are also positive
for AMACR and are scarcely positive for
p63.
Prostate cancer with subtle architectural and
cytological atypia.
(a) In this case, the cancer glands display
crowded growth pattern
(b) The cancer cells have minimum nuclear
enlargement and inconspicuous nucleoli
(c)This focus is negative for basal cell marker
p63 .The cancer diagnosis in such cases
requires a substantial number of cancer
glands and IHC
Histological
Features For and
Against Cancer
Diagnosis in
Biopsy
Quantitative Threshold for Diagnosing
Limited Cancer in Biopsy
 Depending on the architectural and cytological atypia-
more atypia, fewer glands are required to make a
cancer diagnosis.
 At least three glands are required to make a cancer
diagnosis, if there is no full-blown cancer associated
architectural and cytological features.
A Practical Approach to Diagnosis
of Limited Cancer in Needle Biopsy
 Use benign glands as reference and evaluate the
architectural and cytological features of atypical glands
 A definitive cancer diagnosis can be established only when
all three criteria are met:
1. Atypical glands exhibiting major and/or minor
architectural atypia
2. Atypical glands exhibiting cytological atypia
3. Benign processes that may cause architectural and
cytological atypia are carefully considered and ruled out.
Limited prostate cancer.
There are only five cancer glands present in one needle core.
However, they display infiltrative growth pattern
Limited prostate
cancer.
• Significant nuclear enlargement
and hyperchromasia .
• These atypical glands are not
inflamed or atrophic.
• These glands are negative for p63
Benign mimics of prostatic carcinoma
Atypical
Morphological
Features Commonly
Encountered in
Various Benign
Mimics of Prostate
Cancer
Seminal vesicle/ejaculatory duct
epithelium.
• At low power peripherally
located well-formed small
branching glands with cytoplasmic
amphophilia, budding from
central dilated lumina is a
common feature. Well-formed
muscular layer surrounding glands
favors seminal vesicle tissue.
• At higher magnification, the
epithelium lining the lumina and
small glands show nuclear
hyperchromasia and random
pleomorphism (arrows), also
referred to as “monster nuclei.”
• Nuclear pseudoinclusions are
commonly seen.
• Prominent golden-brown
lipofuscin granules (arrowhead)
are typical.
Verumontanum mucosal gland
hyperplasia.
• At low power lobulated collection of
relatively uniform, closely packed,
round, small acini, frequently
accompanied by adjacent urothelial
epithelium (arrow) is a common
presentation.
• Intraluminal brown orange
concretions (arrow) are a frequent
and distinctive feature.
• At high magnification The luminal
cells have small uniform nuclei and
inconspicuous nucleoli. An intact
basal cell layer is present
• Cowper’s glands.
• Composed of tightly circumscribed or
lobulated proliferation of small, uniform acini
lined by mucus-containing cells with a central
duct.
• This dimorphic population of ducts (arrow)
surrounded by acini is characteristic .
Cytological features are bland, including small
nuclei and inconspicuous nucleoli.
• Mucin is present in the intracellular
compartment in contrast to intraluminal
mucin in prostate cancer
• Skeletal muscle is frequently present in stroma
Mesonephric remnant
hyperplasia.
• Glands appear atrophic with
attenuated bland epithelium
and grow in a lobulated or
sometimes infiltrative
pattern.
• Intraluminal dense
eosinophilic secretions
(arrows) and papillary
infoldings and tufts are
common useful features to
distinguish from
adenocarcinoma of the
prostate
Mucinous metaplasia typically involves part of a lobule.
1. Transition to benign atrophic glands in the background is seen.
2. Glands are lined by tall columnar cells with abundant intracytoplasmic
mucin.
3. In contrast to Cowper’s glands, dimorphic duct/acini architecture is not
seen
Simple atrophy, cystic atrophy
a) In simple atrophy, overall architecture of
the glands is maintained with marked
reduction of cytoplasm, creating a
basophilic appearance at low power
b) In cystic atrophy, an undulated glandular
architecture of the normal gland is lost;
glands are round and cystically dilated
with attenuated cytoplasm .
c) Accompanied by inflammation and
sclerotic stroma .
Morphological spectrum of partial atrophy.
The majority of partial atrophy lesions are composed of a lobular arrangement
of crowded glands with stellate/undulating gland lumina, and scant pale clear
cytoplasm, imparting a distinct pale appearance at low power .
• Partial atrophy composed of a disorganized proliferation of predominantly small,
round to occasionally poorly formed glands (arrows).
• In addition to partially atrophic glands, there are several completely atrophic
glands (arrowheads), a very useful diagnostic clue.
• The pale cytoplasm of the lesion is similar to the adjacent benign gland
• At high power, frequent micronucleoli (arrow) are visible. Note pale, clear
cytoplasm placed laterally to the nuclei, lack of nuclear enlargement and
macronucleoli, as well as the presence of few completely atrophic glands within
the focus .
• Partial atrophy showing disorganized growth pattern and predominant
poorly formed glands mimicking cancer.
• Note relatively benign cytology, pale cytoplasm, and few completely
atrophic glands within the focus.
• Immunohistochemistry for basal cell markers demonstrates very patchy
staining with the lack of staining in the majority of glands
Partial atrophy with atypical features,
suspicious for cancer.
1. At low power, several disorganized
glands with partially atrophic
cytoplasm are present. A few
completely atrophic glands are also
present. These features are suggestive
of partial atrophy.
2. At higher magnification, these glands
demonstrated bland cytology.
However,the edge of this lesion
appears infiltrative (arrow, a)
3. IHC identical to cancer
4. Despite the presence of several
features of partial atrophy, one cannot
rule out cancer. Therefore, it is best to
diagnose this case as atypical
suspicious for cancer
• Postatrophic hyperplasia.
• At low power, circumscribed /lobulated
collection of small dark atrophic acini
with round-to-distorted contours
arranged around a larger dilated duct
(arrow; a b).
• The dark appearance of the lesion at low
power may arouse a suspicion for cancer
but is due to scant cytoplasm rather than
abundant amphophilic/granular
cytoplasm seen in cancer.
 At high magnification, the acini are lined by cuboidal secretory
cells with minimal nuclear enlargement, increased nucleus-to-
cytoplasmic ratio, and small but visible nucleoli. The stroma is usually
sclerotic
• Pseudoinfiltrative growth patterns in
focal atrophy. (a–b)
• Benign atrophic glands with
haphazard or pseudoinfiltrative
growth pattern may raise concern at
low-power examination (a and b).
• However, the pattern of infiltration
is like a “patch” different than the
true infiltration pattern with cancer
glands situated between or on both
sides of the benign glands
Adenosis (atypical adenomatous hyperplasia).
• a. At low power, adenosis is characterized by a circumscribed collection of
variably sized glands
• b. Within the nodule, small round acini are admixed with larger
benign-appearing glands with papillary infolding (arrows). There are no
obvious cytoplasmic or cytological differences between them. Essentially,
small and large glands merge with each other imperceptibly.
• c. At high power, the columnar cells have abundant pale
to clear cytoplasm and bland-appearing nuclei with
inconspicuous to small nucleoli .
• d. The stroma between the glands is cellular, a feature to
suggest a benign reactive nature .
• (e)Basal cell markers typically demonstrate a discontinuous/patchy-
staining pattern, with some glands lacking the staining .
• (f)A small percentage (~30%) of adenosis lesions may demonstrate
mild-to-moderate AMACR expression
Basal cell hyperplasia.
(a). A well-circumscribed nodule of basal cell hyperplasia, also referred to
as basal cell adenoma is a form of epithelial hyperplasia in which glands
have markedly stratified lining cells with high N:C ratio, and appears
basophilic at low magnification
(b).In incomplete basal cell hyperplasia, a luminal differentiation is
Seen.
(c) In complete basal cell hyperplasia, dark-staining nests are seen in a cellular
stroma.
• Note the lack of lumen formation. The presence of cellular spindly stroma is
a feature suggestive of the benign proliferative nature
• In basal cell hyperplasia, nuclei are stratified, arranged like a pack of
cigar without visible cytoplasm and are coffee bean–like with frequent
grooves and vesicular glassy chromatin.
(d).Prominent nucleoli are frequently seen (arrows in d).
Basal cell hyperplasia
(e)can also present with adenoid cystic carcinoma-like cribriform architecture
simulating cribriform carcinoma.
• Also note cellular spindly stroma
(f)Intraluminal calcifications and cytoplasmic hyaline globules can be
seen in basal cell hyperplasia
Basal cell hyperplasia in prostate
needle biopsy.
a) Dark-staining nests with
stratified epithelium are seen in a
haphazard pattern
b) Nuclei are stratified with frequent
prominent nucleoli
c) Immunohistochemical markers
for basal cell detection are helpful
in difficult cases (c, p63)
Diagnostic Approach to
Prostate Basal
Cell Lesions
Nephrogenic adenoma.
A classical nephrogenic adenoma with both papillary and underlying tubular
components.
(a) Polypoid or papillary component has edematous stroma without well-
defined fibrovascular cores and lining epithelium is cuboidal and lacks
stratification.
• Underlying tubules are variably sized and mimic renal tubules. Note
thickened eosinophilic basement membrane surrounding tubules (arrow),
one of the characteristic features of nephrogenic adenoma
(b) Prostatic urethra biopsy exhibits exclusively a tubular component,
mimicking a prostate adenocarcinoma
Nephrogenic adenoma
• The tubules are lined by cuboidal hobnail epithelium.
• Degenerative cytological atypia and features such as intraluminal blue
mucin can be encountered.
• Background inflammation and calcifications are common (c and d).
• Nephrogenic adenoma
(e) presenting predominantly with nested
(f) signet ring cell like pattern.
• These patterns may be mistaken for nested urothelial carcinoma and poorly
differentiated prostate adenocarcinoma.
• Hyalinized basement membrane surrounding glands (f) and superficial nature
of the lesion (e) are useful features to suggest the diagnosis
(g). Rarely, nephrogenic adenoma may
present with prominent fibrous and
myxoid component
(h). Cytoplasmic AMACR expression is
present in the vast majority of
nephrogenic adenoma,
(i)Nuclear transcription factors PAX-
2 or PAX-8 are expressed in
nephrogenic adenoma and are helpful
markers to support the diagnosis in
difficult cases
Central zone histology mimicking
HGPIN.
(a) Central zone histology is typically a
mimicker of HGPIN; however,
prominent cribriform architecture
in some cases may mimic cancer.
• In the central zone, glands are
complex with frequent papillation
and undulating architecture with
pseudostratified lining epithelium
• At low magnification, glands
demonstrate distinct cytoplasmic
eosinophilia
(b). Roman bridges and cribriform
architecture are common
• In contrast to HGPIN, nuclei
stream parallel to bridges in
comparison to perpendicular
orientation in HGPIN
(c). The cytological atypia is seen in basal cells (arrow), a feature helpful to
differentiate from HGPIN or cancer
Before making a diagnosis of HGPIN or atypia in biopsies from the base
area of the prostate, central zone histology should be ruled out
Clear cell cribriform hyperplasia.
• Clear cell cribriform hyperplasia represents a spectrum of benign prostate
hyperplasia and therefore is typically encountered in the transition zone of
the prostate.
(a)There is a nodular proliferation of nonconfluent cribriform glands with
clear to eosinophilic cytoplasm
(b)The cells forming the central lumina are cuboidal to low columnar
secretory-type cells, with uniform round nuclei and clear cytoplasm.
• The glands (arrows) are rimmed with a prominent basal cell layer
Malakoplakia.
• There is a diffuse sheet-like proliferation of pink epithelioid histiocytes,
accompanied by other inflammatory cells, similar to nonspecific
xanthogranulomatous prostatitis.
• The histiocytic nature of epithelioid cells and the presence of Michaelis-Gutmann
bodies (arrow) suggest the diagnosis of malakoplakia
Sclerosing adenosis mimicking high-grade prostate carcinoma.
• This specimen demonstrates a proliferation of poorly formed and complex glands
mimicking high-grade prostate carcinoma.
• Lowpower recognition is a key.
(a). It typically forms a well-circumscribed nodule of tightly packed glands
(b). At high magnification, glands demonstrate complex proliferation, poorly formed
glands with slit-like lumina, fused glands, and even single cells with signet ring
cell-like features, mimicking high-grade cancer
(c)Stroma surrounding the glands is cellular and hyalinized (arrows).
(d)Prominent nucleoli, crystalloids, and blue mucin are common
(e)Basal cells are highlighted with basal cell marker p63.
(f) Basal cells undergo myoepithelial metaplasia and show coexpression
of basal cell markers and S-100 and muscle-specific actin.
• When one or more well-circumscribed cellular lesions mimicking
high-grade prostate cancer are encountered in TURP or biopsies
from the transition zone of the prostate, sclerosing adenosis should
be ruled out
Paraganglia mimicking high-grade
prostate carcinoma and extraprostatic
extension.
(a)At low power, paraganglia consist
of small, solid nests of cells with
clear cytoplasm separated by a
delicate vascular network,
mimicking high-grade Gleason
pattern 4 or 5 prostate carcinoma.
• Its presence in adipose tissue ,
impart an impression of
extraprostatic tumor extension.
(b)At high power, the cells have clear
to amphophilic, finely granular
cytoplasm. Random cytological
atypia may be seen and nuclei are
often hyperchromatic, but nucleoli
are inconspicuous.
Recognition of the delicate vascular network pattern referred to as the
“Zellballen” arrangement is an important clue.
In difficult cases, positive neuroendocrine markers support the diagnosis
(synaptophysin)
• Xanthomatous infiltrate in prostate
needle biopsy.
(a) Xanthoma cells grow in a diffuse
infiltrative pattern, mimicking
poorly differentiated prostate
carcinoma with foamy features .
(b)Lack of any glandular
differentiation and relatively bland
nuclear features suggests the
diagnosis of xanthomatous infiltrate
• In small needle biopsysamples, a
panel of immunohistochemical
markers of histiocytic lineage (CD-
68) and pancytokeratin may be
necessary to rule out carcinoma.
• Presence of other inflammatory
cells would support the diagnosis of
xanthomatous infiltrate
Commonly Used
Immunohistochemical
Markers for Diagnosis
of Prostate Cancer in
Biopsy
Basal Cell Markers
 Types of basal cell markers
1. HMWCK: cytoplasmic intermediate filaments detected by several antibody
preparations (34bE12, CK5/6, CK14)
2. p63: nuclear antigen
3. Basal cell cocktail (34bE12+ p63)
 Staining pattern in prostate cancer
1. Prostate carcinoma lacks staining for basal cell markers
2. HMWCK may rarely be positive in cancer cells, but not in basal cell
distribution, due to excessive antigen retrieval and staining
3. p63 can rarely be found in cancer cells with uniform and non-basal cell
distribution
 Diagnostic utility
 A negative basal cell marker staining in atypical glands morphologically
suspicious for cancer supports a cancer diagnosis
 Pitfalls
 Adenosis, partial atrophy, high-grade prostatic intraepithelial neoplasia
(HGPIN) may have discontinuous or even absent basal cell lining
a-Methylacyl CoA Racemase (AMACR, P504S)
 Types of antibodies
 Monoclonal (P504S) and polyclonal, both with comparable
sensitivity and specificity
 Staining pattern in prostate cancer
 Apical cytoplasmic granular staining
 Diagnostic utility
1. Positive AMACR staining in atypical glands
morphologically suspicious for cancer supports a cancer
diagnosis
2. Positive AMACR may convert an ATYP to cancer
diagnosis where morphology is suspicious for but not
diagnostic of cancer and basal cell markers are negative
Points to remember in Gleason
Grading on needle biopsy
 Gleason grade is solely based on architectural pattern, cytologic
features are not factored in.
 Both the primary (predominant) and secondary (second most
prevalent) architectural patterns are identified and assigned a
grade from 1 to 5, with 1 being the most differentiated and 5
being undifferentiated.
 If a tumor has only one histologic pattern, then for uniformity,
the primary and secondary patterns are given the same grade.
 Full Gleason score is assigned to even to small foci of cancer on
needle biopsy, because it has been demonstrated that the grade
assigned to these minimal cancers is just as accurate compared
with cases with more extensive cancer on biopsy.
 In setting of three grades on biopsy where the highest
grade is the least common, the highest grade is taken
as the secondary pattern.
 One should assign a separate Gleason score to each
involved core, especially when one of the cores is high
grade (Gleason score 4 + 4 = 8) and other cores have
lower-grade cancer.
Current Concepts of Gleason
Grading
1. Gleason pattern 1 or 2 should be rarely if ever applied in the
biopsy setting
2. Gleason grade in the biopsy setting essentially starts with
Gleason pattern 3
3. A few malignant glands located between benign glands
indicate pattern 3 (small focus of cancer does not necessarily
mean low-grade cancer)
4. Virtually all cribriform carcinomas represent pattern 4 or 5 if
associated with necrosis
5. Clusters of glands with poorly formed glandular lumina where
tangential sectioning is ruled out represent Gleason pattern 4
6. Percentage of pattern 4 in the setting of Gleason score 7
(3 + 4 versus 4 + 3) bears prognostic importance
7. Multiple cores with cancer of different Gleason grades,
grade information of individual core(s) better correlates
with Gleason grade of radical prostatectomy
8. Any amount of higher pattern in the needle biopsy
should be reported
9. In the setting of high-grade tumor of large volume, a
small amount (< 5%) of lower-grade pattern can be
ignored and need not be reported
10. Tertiary pattern 5 in the biopsy should be reported as the
secondary pattern in the needle biopsy due to its
prognostic significance
11. Many “special” types of prostate cancers are considered
examples of Gleason pattern 4 or 5
Future Trends in Prostate Biopsy Sampling and
Its Clinical Applications
References
 Springers Prostate Biopsy Interpretation: An
Illustrated Guide by Shah and Zhou.
 Lippincotts Williams and Wilkins Prostate biopsy
interpretation series by Epstein and Yang.
 Robbins and Cotran pathologic basis of disease 9e.
 Sternberg’s Diagnostic surgical pathology.
Thank you……..!

More Related Content

What's hot

testicular tumors
testicular tumorstesticular tumors
testicular tumors
DrAyush Garg
 
Management of renal cell carcinoma - presented at Asian Oncology Summit 2013
Management of renal cell carcinoma - presented at Asian Oncology Summit 2013Management of renal cell carcinoma - presented at Asian Oncology Summit 2013
Management of renal cell carcinoma - presented at Asian Oncology Summit 2013
Siewhong Ho
 
Testicular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Testicular tumors-Cassification, Biomarkers and Staging by Dr RajeshTesticular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Testicular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Rajesh Sinwer
 
Renal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRenal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRHMBONCO
 
Cystic tumours of pancreas
Cystic tumours of pancreasCystic tumours of pancreas
Cystic tumours of pancreas
Santosh Narayankar
 
Bladder carcinoma
Bladder carcinomaBladder carcinoma
Bladder carcinoma
Jyotindra Singh
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
Kiran Ramakrishna
 
Retroperitoneal lymph node dissection kaushal
Retroperitoneal lymph node dissection kaushalRetroperitoneal lymph node dissection kaushal
Retroperitoneal lymph node dissection kaushal
yadavkaushal
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
LAKSHMI DEEPTHI GEDELA
 
Renal Tumors, Renal Cell Carcinoma- Dr. Vandana
Renal Tumors, Renal Cell Carcinoma-  Dr. VandanaRenal Tumors, Renal Cell Carcinoma-  Dr. Vandana
Renal Tumors, Renal Cell Carcinoma- Dr. Vandana
Dr Vandana Singh Kushwaha
 
Testicular tumors
Testicular tumorsTesticular tumors
Testicular tumors
Harshita Mehrotra
 
Trus biopsy prostate
Trus biopsy prostateTrus biopsy prostate
Trus biopsy prostate
Parth Nathwani
 
Pathology of testicular tumors
Pathology of testicular tumorsPathology of testicular tumors
Pathology of testicular tumors
Nebiyusemegnew
 
Wilms tumor
Wilms tumorWilms tumor
Wilms tumor
vrinda singla
 
TESTICULAR TUMOURS
TESTICULAR TUMOURSTESTICULAR TUMOURS
TESTICULAR TUMOURS
Dr. Roopam Jain
 
liver mass - how to investigate?
liver mass - how to investigate?liver mass - how to investigate?
liver mass - how to investigate?
hr77
 
Grossing colon.pptx
Grossing colon.pptxGrossing colon.pptx
Grossing colon.pptx
Shahin Hameed
 
Yokohama system cytology
Yokohama system cytologyYokohama system cytology
Yokohama system cytology
BPS GMC (W) KHANPUR KALAN SONEPAT
 
Whipple's specimen grossing
Whipple's  specimen grossingWhipple's  specimen grossing
Whipple's specimen grossing
Dr.Pooja Dwivedi
 
Prostate carcinoma- Prostate biopsy
Prostate  carcinoma- Prostate biopsyProstate  carcinoma- Prostate biopsy
Prostate carcinoma- Prostate biopsy
GovtRoyapettahHospit
 

What's hot (20)

testicular tumors
testicular tumorstesticular tumors
testicular tumors
 
Management of renal cell carcinoma - presented at Asian Oncology Summit 2013
Management of renal cell carcinoma - presented at Asian Oncology Summit 2013Management of renal cell carcinoma - presented at Asian Oncology Summit 2013
Management of renal cell carcinoma - presented at Asian Oncology Summit 2013
 
Testicular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Testicular tumors-Cassification, Biomarkers and Staging by Dr RajeshTesticular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Testicular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
 
Renal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRenal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And Management
 
Cystic tumours of pancreas
Cystic tumours of pancreasCystic tumours of pancreas
Cystic tumours of pancreas
 
Bladder carcinoma
Bladder carcinomaBladder carcinoma
Bladder carcinoma
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
 
Retroperitoneal lymph node dissection kaushal
Retroperitoneal lymph node dissection kaushalRetroperitoneal lymph node dissection kaushal
Retroperitoneal lymph node dissection kaushal
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
 
Renal Tumors, Renal Cell Carcinoma- Dr. Vandana
Renal Tumors, Renal Cell Carcinoma-  Dr. VandanaRenal Tumors, Renal Cell Carcinoma-  Dr. Vandana
Renal Tumors, Renal Cell Carcinoma- Dr. Vandana
 
Testicular tumors
Testicular tumorsTesticular tumors
Testicular tumors
 
Trus biopsy prostate
Trus biopsy prostateTrus biopsy prostate
Trus biopsy prostate
 
Pathology of testicular tumors
Pathology of testicular tumorsPathology of testicular tumors
Pathology of testicular tumors
 
Wilms tumor
Wilms tumorWilms tumor
Wilms tumor
 
TESTICULAR TUMOURS
TESTICULAR TUMOURSTESTICULAR TUMOURS
TESTICULAR TUMOURS
 
liver mass - how to investigate?
liver mass - how to investigate?liver mass - how to investigate?
liver mass - how to investigate?
 
Grossing colon.pptx
Grossing colon.pptxGrossing colon.pptx
Grossing colon.pptx
 
Yokohama system cytology
Yokohama system cytologyYokohama system cytology
Yokohama system cytology
 
Whipple's specimen grossing
Whipple's  specimen grossingWhipple's  specimen grossing
Whipple's specimen grossing
 
Prostate carcinoma- Prostate biopsy
Prostate  carcinoma- Prostate biopsyProstate  carcinoma- Prostate biopsy
Prostate carcinoma- Prostate biopsy
 

Viewers also liked

TRUS in Evaluation of Male Infertility
TRUS in Evaluation of Male InfertilityTRUS in Evaluation of Male Infertility
TRUS in Evaluation of Male Infertility
Siewhong Ho
 
Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar
Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar
Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar
Dr. Muhammad Bin Zulfiqar
 
Testicular tumors
Testicular tumorsTesticular tumors
Testicular tumors
Narmada Tiwari
 
Multidisciplinarity and the Prostate Cancer Unit
Multidisciplinarity and the Prostate Cancer UnitMultidisciplinarity and the Prostate Cancer Unit
Multidisciplinarity and the Prostate Cancer Unit
Europa Uomo EPAD
 
LAB TESTING PRICING
LAB TESTING PRICINGLAB TESTING PRICING
LAB TESTING PRICING
Direct Healthcare Access II
 
Modelling your way out of the poo: predicting the impact of early diagnosis o...
Modelling your way out of the poo: predicting the impact of early diagnosis o...Modelling your way out of the poo: predicting the impact of early diagnosis o...
Modelling your way out of the poo: predicting the impact of early diagnosis o...
David Halsall
 
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...nataliejleigh
 
Endometrial stromal tumours revisited
Endometrial stromal tumours revisitedEndometrial stromal tumours revisited
Endometrial stromal tumours revisited
drtousif
 
Tumors of the Endometrium
Tumors of the EndometriumTumors of the Endometrium
Tumors of the EndometriumNajla El Bizri
 
Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer   modernising the diagnostic pathway 2013-06-11 by Marc LaniadoProstate cancer   modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc LaniadoMarc Laniado
 
Testicular biopsy
Testicular biopsyTesticular biopsy
Testicular biopsydrsadia
 
Parasitic diseases of the central nervous system
Parasitic diseases of the central nervous systemParasitic diseases of the central nervous system
Parasitic diseases of the central nervous system
Shahin Hameed
 
Presentation1.pptx, radiological imaging of male infertility.
Presentation1.pptx, radiological imaging of male infertility.Presentation1.pptx, radiological imaging of male infertility.
Presentation1.pptx, radiological imaging of male infertility.Abdellah Nazeer
 
Eye & orbit tumors anatomy, epidemiology, pathology by himani
Eye & orbit tumors anatomy, epidemiology, pathology by himaniEye & orbit tumors anatomy, epidemiology, pathology by himani
Eye & orbit tumors anatomy, epidemiology, pathology by himani
Himani Manchala
 
germ cell tumours of ovary
germ cell tumours of ovarygerm cell tumours of ovary
germ cell tumours of ovary
Sreelasya Kakarla
 
Amol april prostate cancer imaging
Amol april prostate cancer imagingAmol april prostate cancer imaging
Amol april prostate cancer imaging
Amol Gulhane
 
Musle biopsy
Musle biopsyMusle biopsy
Musle biopsy
Dr Neha Mahajan
 
Germ cell tumors of ovary
Germ cell tumors of ovaryGerm cell tumors of ovary
Germ cell tumors of ovary
ashish223
 
Trauma axial skeleton Dr. Muhammad Bin Zulfiqar
Trauma axial skeleton Dr. Muhammad Bin ZulfiqarTrauma axial skeleton Dr. Muhammad Bin Zulfiqar
Trauma axial skeleton Dr. Muhammad Bin Zulfiqar
Dr. Muhammad Bin Zulfiqar
 

Viewers also liked (20)

TRUS in Evaluation of Male Infertility
TRUS in Evaluation of Male InfertilityTRUS in Evaluation of Male Infertility
TRUS in Evaluation of Male Infertility
 
Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar
Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar
Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar
 
Testicular tumors
Testicular tumorsTesticular tumors
Testicular tumors
 
Multidisciplinarity and the Prostate Cancer Unit
Multidisciplinarity and the Prostate Cancer UnitMultidisciplinarity and the Prostate Cancer Unit
Multidisciplinarity and the Prostate Cancer Unit
 
LAB TESTING PRICING
LAB TESTING PRICINGLAB TESTING PRICING
LAB TESTING PRICING
 
Modelling your way out of the poo: predicting the impact of early diagnosis o...
Modelling your way out of the poo: predicting the impact of early diagnosis o...Modelling your way out of the poo: predicting the impact of early diagnosis o...
Modelling your way out of the poo: predicting the impact of early diagnosis o...
 
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...
 
Endometrial stromal tumours revisited
Endometrial stromal tumours revisitedEndometrial stromal tumours revisited
Endometrial stromal tumours revisited
 
Tumors of the Endometrium
Tumors of the EndometriumTumors of the Endometrium
Tumors of the Endometrium
 
Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer   modernising the diagnostic pathway 2013-06-11 by Marc LaniadoProstate cancer   modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc Laniado
 
Board review 2
Board review 2Board review 2
Board review 2
 
Testicular biopsy
Testicular biopsyTesticular biopsy
Testicular biopsy
 
Parasitic diseases of the central nervous system
Parasitic diseases of the central nervous systemParasitic diseases of the central nervous system
Parasitic diseases of the central nervous system
 
Presentation1.pptx, radiological imaging of male infertility.
Presentation1.pptx, radiological imaging of male infertility.Presentation1.pptx, radiological imaging of male infertility.
Presentation1.pptx, radiological imaging of male infertility.
 
Eye & orbit tumors anatomy, epidemiology, pathology by himani
Eye & orbit tumors anatomy, epidemiology, pathology by himaniEye & orbit tumors anatomy, epidemiology, pathology by himani
Eye & orbit tumors anatomy, epidemiology, pathology by himani
 
germ cell tumours of ovary
germ cell tumours of ovarygerm cell tumours of ovary
germ cell tumours of ovary
 
Amol april prostate cancer imaging
Amol april prostate cancer imagingAmol april prostate cancer imaging
Amol april prostate cancer imaging
 
Musle biopsy
Musle biopsyMusle biopsy
Musle biopsy
 
Germ cell tumors of ovary
Germ cell tumors of ovaryGerm cell tumors of ovary
Germ cell tumors of ovary
 
Trauma axial skeleton Dr. Muhammad Bin Zulfiqar
Trauma axial skeleton Dr. Muhammad Bin ZulfiqarTrauma axial skeleton Dr. Muhammad Bin Zulfiqar
Trauma axial skeleton Dr. Muhammad Bin Zulfiqar
 

Similar to Prostate biopsy

Male genital 3
Male genital 3Male genital 3
Male genital 3
Dr.Babai Halder
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx
SAMOEINESH
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx
SAMOEINESH
 
paris presentation.pptx
paris presentation.pptxparis presentation.pptx
paris presentation.pptx
KarishmaBhuyan
 
Male genital system
Male genital systemMale genital system
Male genital system
Gopi sankar
 
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptxUPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
jenishJebadurai1
 
Update on Neoplasm of Nervous system in Livestock and their Dignosi
Update on Neoplasm of Nervous system in Livestock and their DignosiUpdate on Neoplasm of Nervous system in Livestock and their Dignosi
Update on Neoplasm of Nervous system in Livestock and their Dignosi
Rahul Kadam
 
Prostate
ProstateProstate
Cervix-bethesda system | Abdul Quddus
Cervix-bethesda system | Abdul QuddusCervix-bethesda system | Abdul Quddus
Cervix-bethesda system | Abdul Quddus
Abdul Quddus
 
Beningn salivary gland tumor 3/cosmetic dentistry courses
Beningn salivary gland tumor 3/cosmetic dentistry coursesBeningn salivary gland tumor 3/cosmetic dentistry courses
Beningn salivary gland tumor 3/cosmetic dentistry courses
Indian dental academy
 
Prostate Pathology
Prostate PathologyProstate Pathology
Prostate PathologyMCG Urology
 
Pap smaer cytology
Pap smaer cytologyPap smaer cytology
Pap smaer cytology
FereshtehAmeli1
 
Cervix bethesda system
Cervix bethesda systemCervix bethesda system
Cervix bethesda system
Dr. Sobia Khalid
 
Neoplasia, two
Neoplasia, twoNeoplasia, two
Neoplasia, twobilalrana
 
An approach to proliferative disease of breast .pptx
An approach to proliferative disease of breast .pptxAn approach to proliferative disease of breast .pptx
An approach to proliferative disease of breast .pptx
YogeetaTanty1
 
Ca prostate
Ca prostateCa prostate
Ca prostate
dr sajid Abbasi
 
Testicular tumors.pptx
Testicular tumors.pptxTesticular tumors.pptx
Testicular tumors.pptx
Utkarsh Singhal
 
Various types of endometrial carcinoma
Various types of endometrial carcinomaVarious types of endometrial carcinoma
Various types of endometrial carcinoma
Dr. Pritika Nehra
 
PROSTATIC TUMORS
PROSTATIC TUMORSPROSTATIC TUMORS
PROSTATIC TUMORS
Sindhuja Yella
 

Similar to Prostate biopsy (20)

Male genital 3
Male genital 3Male genital 3
Male genital 3
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx
 
paris presentation.pptx
paris presentation.pptxparis presentation.pptx
paris presentation.pptx
 
FNAC of breast
FNAC of breastFNAC of breast
FNAC of breast
 
Male genital system
Male genital systemMale genital system
Male genital system
 
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptxUPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
UPDATES IN THE BETHESDA SYSTEM FOR REPORTING THYROID.pptx
 
Update on Neoplasm of Nervous system in Livestock and their Dignosi
Update on Neoplasm of Nervous system in Livestock and their DignosiUpdate on Neoplasm of Nervous system in Livestock and their Dignosi
Update on Neoplasm of Nervous system in Livestock and their Dignosi
 
Prostate
ProstateProstate
Prostate
 
Cervix-bethesda system | Abdul Quddus
Cervix-bethesda system | Abdul QuddusCervix-bethesda system | Abdul Quddus
Cervix-bethesda system | Abdul Quddus
 
Beningn salivary gland tumor 3/cosmetic dentistry courses
Beningn salivary gland tumor 3/cosmetic dentistry coursesBeningn salivary gland tumor 3/cosmetic dentistry courses
Beningn salivary gland tumor 3/cosmetic dentistry courses
 
Prostate Pathology
Prostate PathologyProstate Pathology
Prostate Pathology
 
Pap smaer cytology
Pap smaer cytologyPap smaer cytology
Pap smaer cytology
 
Cervix bethesda system
Cervix bethesda systemCervix bethesda system
Cervix bethesda system
 
Neoplasia, two
Neoplasia, twoNeoplasia, two
Neoplasia, two
 
An approach to proliferative disease of breast .pptx
An approach to proliferative disease of breast .pptxAn approach to proliferative disease of breast .pptx
An approach to proliferative disease of breast .pptx
 
Ca prostate
Ca prostateCa prostate
Ca prostate
 
Testicular tumors.pptx
Testicular tumors.pptxTesticular tumors.pptx
Testicular tumors.pptx
 
Various types of endometrial carcinoma
Various types of endometrial carcinomaVarious types of endometrial carcinoma
Various types of endometrial carcinoma
 
PROSTATIC TUMORS
PROSTATIC TUMORSPROSTATIC TUMORS
PROSTATIC TUMORS
 

Recently uploaded

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 

Recently uploaded (20)

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 

Prostate biopsy

  • 2. Topics to be covered 1. Indications 2. Technique of biopsy 3. General approach to prostate needle biopsy 4. Normal histology 5. Histologic variations of normal prostatic tissue 6. Histologic features specific for prostate cancer 7. Limited cancer on needle biopsy 8. Benign mimics of prostate cancer 9. IHC 10. Current concepts in gleason score
  • 3. Indications of prostate biopsy  Symptoms - frequency  Increased serum PSA  Digital Rectal Examination – hard prostate
  • 4. Biopsy Techniques for Prostate Cancer Detection
  • 5. Transrectal and Transperineal Biopsy Approaches for Prostate Cancer Detection
  • 6. Biopsy Parameters That Impact Prostate Cancer Detection Rate in Prostate Needle Biopsy  Factors related to biopsy procedure and operator 1. Number of cores obtained 2. Laterality of the biopsy procedure (paramedian versus laterally directed biopsy approach) 3. Transrectal versus transperineal (anterior-based) approach 4. Operator experience and skill  Factors related to pathology laboratory practice 1. Number of needle cores embedded in cassette (ideal 1–2 core/cassette) 2. Tissue-sectioning protocol and number of levels examined 3. Histotechnologist’s skill 4. Pathologist’s skill and experience
  • 7. General Approach to Prostate Needle Biopsy Evaluation 1. Use benign glands as reference and study their low-power architectural features and high-power cytological features (cytoplasmic characteristics, nuclear size and morphology, and nucleolar prominence in secretory and basal cells) 2. Scan biopsy cores to look for glands that appear different from and do not fit in with benign glands 3. Evaluate the architectural features at low power and cytological features at high power of atypical glands 4. Cancer diagnosis is made based on hematoxylin–eosin stain (H&E) examination; use ancillary immunohistochemistry prudently to support H&E impression
  • 8. Normal histology of prostate  Glandular component is composed of acini and ducts, which is subdivided into large (primary, major, excretory) and peripheral (secondary, minor)  Acini & ducts contain secretory cells, basal cells & scattered neuroendocrine cells  Secretory cells  located in the luminal side, contribute to products of seminal fluid, like Prostatic acid phosphatase (PAP) and Prostate-specific antigen (PSA)  Secretory cells also co-express various keratins & vimentin  Normal secretion is a neutral mucosubstance ( most adenocarcinomas secrete acidic & neutral mucin)
  • 9. In this benign gland, the luminal contour shows tufts and papillary infoldings. The tall secretory epithelial cells have pale clear cytoplasm and uniform round or oval nuclei. Prominent nucleoli are not seen. Many basal cells can be identified
  • 10.  Basal cells  Form a thin continuous layer that separates secretory cells from basement membrane  Cell nuclei are cigar-shaped or resembles fibroblasts & are oriented parallel to BM  Inconspicuous in benign glands  Characteristically contains keratin 34Eβ12, CK8.2, 312 C8-1  Normally, these cells do not have phenotype of myo- epithelial cells as they are negative for S-100 or SMA  Do not express PSA or PAP
  • 11. This benign gland contains corpora amylacea. Even at low magnification, basal cells can be clearly seen. Compare this with next slide which highlights the basal cell layer with the immunostain for high molecular weight cytokeratin 34bE12.
  • 12. Basal cells are present in a continuous layer in most benign glands. The antibodies to high molecular weight cytokeratin 34bE12 stain basal cells but not secretory or stromal cells in the prostate. Besides cancer, the basal cell layer may be disrupted in atrophy, inflammation, atypical adenomatous hyperplasia (adenosis), and high-grade PIN.
  • 13.  Neuroendocrine cells  express chromogranin A & B, secretogranin II, and hormones like somatostatin & calcitonin  Co-express PSA suggesting common origin with secretory cells
  • 14. Neuroendocrine cells are seen in benign prostate, high-grade PIN, and cancer. They are most abundant near verumontanum. In this image, many neuroendocrine cells with large eosinophilic granules (Paneth cell-like change) are seen in atrophic prostate glands
  • 15.  Large prostatic ducts  lined by transitional epithelium which is continuous with & indistinguishable from lining of prostatic urethra  Do not display umbrella cells, but a single layer of columnar cells that are PSA & PAP positive  Prostatic stroma  Mainly composed of smooth muscle fibres, which functions to squeeze out prostatic secretions  Peripheral nerves are evenly distributed in the apex, mid gland & base
  • 16. Skeletal muscle fibers of the urogenital diaphragm extend into the apical and anterior peripheral regions of the prostate. Not infrequently, skeletal muscle fibers are seen in needle biopsies from those regions
  • 17. Ganglia found in prostate needle biopsies should not be mistaken for high-grade carcinoma. Note the intracellular pigment and satellite cells around neurons.
  • 18. Benign prostatic glands may abut nerves. Occasionally, they may even partially or completely wrap around a nerve. This should not reflexly lead to the diagnosis of adenocarcinoma with perineural invasion. The gland in question in this image lacks enlarged nuclei or nucleoli and shows scattered basal cells.
  • 19. A. Corpora amylacea are inspissated secretions that may have a lamellated appearance. Usually they are pink or purple in appearance. Sometimes they may be golden-brown. B. This image shows a round eosinophilic corpus amylaceum in an atrophic gland. Corpora amylacea are more commonly seen in benign glands and are rare in carcinomas. Over time, they may calcify and form prostatic calculi. A B +-o 
  • 20. ;y7
  • 21. Histologic Variations of Normal Prostate Tissue  Atrophy  Basal cell hyperplasia  Urothelial metaplasia  Perineural abutment  Glands within skeletal muscle fibers  Irregular prostate–periprostatic interface
  • 22. Atrophic prostate Glands retain lobulated architecture. Cystic dilatation is common. Glands appear dark due to reduced cytoplasm.
  • 23. Urothelial metaplasia. A form of basal cell hyperplasia, urothelial metaplasia consists of stratified basal cells with longitudinal nuclear grooves arranged perpendicular to the basement membrane
  • 24. Basal cell hyperplasia. (a). Prostate glands are rimmed with one or several layers of basal cells (b). Basal cells have scant cytoplasm and round-to-oval hyperchromatic nuclei. They are positive for basal cell markers such as p63. Some basal cells are stratified and have prominent nucleoli and may be mistaken for HGPIN. Calcification can also be seen.
  • 25. Perineural abutment. (a). A benign prostate gland abuts and loosely encircles a nerve fiber (b) Has to be distinguished from perineural invasion by prostate cancer. In difficult cases, immunostains for basal cells, such as p63, can be used to confirm the benign nature of the glands
  • 26. Prostate glands within skeletal muscle fibers. Skeletal muscle can be found intraprostatically, usually in the apex and anterior fibromuscular layer. Prostate glands can be found within the skeletal muscle fibers; therefore, finding cancer glands within the skeletal muscle fibers should not be interpreted as extraprostatic extension
  • 27. Irregular prostate–periprostatic interface. The prostate does not have a true capsule. Cancer glands intermixed with fat in needle biopsy can be interpreted as extraprostatic extension by cancer
  • 28. Histological Features Considered Specific for and Diagnostic of Cancer  Three features have not been reported in benign glands and are considered specific for prostate cancer:  Mucinous fibroplasia (collagenous micronodules)  Glomerulation  Perineural invasion  Cancer diagnosis can be rendered when one of the three features is present in biopsy
  • 29.  Mucinous fibroplasia  It is acellular or hypocellular hyalinized stroma within or outside cancer glands (arrows), and results from hyalinization of extravasated mucin
  • 30. Glomerulation: It results from the intraluminal proliferation of cancer cells that forms balls or tufts within cancer glands, superficially resembling renal glomeruli
  • 31. l Perineural invasion: It is defined as tight circumferential or near circumferential encircling of a nerve fiber by cancer glands. It should be distinguished from perineural abutment by benign glands.
  • 32. Major features (strongly associated with cancer and rarely seen in noncancer lesions) 1. Abnormal architectural pattern  Infiltrative growth pattern  Large cribriform glands with irregular contour  Single or cords of atypical cells  Solid nests with or without comedo necrosis 2. Absence of basal cells  Can be confirmed by basal cell marker immunohistochemistry 3. Nuclear atypia  Nuclear enlargement  Prominent nucleoli  Hyperchromasia
  • 33. 1: abnormal architectural pattern –infiltrative growth. •Most characteristic growth pattern for prostate cancer, with cancer glands situated between and on both sides of the larger and paler benign glands. •This growth pattern is indicative of invasion. The cancer glands are typically small with rigid round lumens as opposed to large benign glands with undulating luminal borders.
  • 34. Abnormal architectural pattern – crowded glands. •Cancer glands are closely packed and more crowded than the adjacent benign glands, and are often circumscribed without infiltrative pattern. •This should raise a suspicion for cancer. •However, such growth pattern may also be seen in adenosis (atypical adenomatous hyperplasia), which should always be considered and ruled out before a cancer diagnosis is rendered
  • 35. Abnormal architectural pattern – haphazardly arranged glands without accompanying benign glands. The cancer glands grow in a haphazard fashion and dissect stroma and muscle bundles without accompanying benign glands
  • 36. Abnormal architectural pattern – single or cords of atypical cells. Single cancer cells infiltrate in the stroma. They also form short cords
  • 37. Abnormal architectural pattern – irregular cribriform structure. Cancer glands demonstrate large cribriform architecture with irregular and infiltrative borders
  • 38. Abnormal architectural pattern –solid nests. Cancer cells form solid nests without discernible lumens
  • 39. 2: absence of basal cells. a. Cancer glands are devoid of basal cells on H&E examination b. Confirmed by immunostain for basal cell marker p63 which is negative
  • 40. Partial atrophy with patchy basal cells. (a). Basal cells can be absent in few benign glands also, such as partial atrophy (b). Basal cell immunostain for p63 demonstrates focal staining in some glands and complete absence of staining in other glands However, glands with and without basal cell lining have identical cytological features. Other noncancerous lesions that often demonstrate patchy or absent basal cells include adenosis and HGPIN
  • 41. 3: Nuclear atypia – nuclear enlargement. Using the adjacent benign glands (right lower of the image) as reference, the cancer cells have significantly enlarged nuclei
  • 42. 3: Nuclear atypia – prominent nucleoli. (a) Cancer cells have prominent nucleoli (b) Nucleolar prominence depends on the several tissue processing factors, including fixation, tissue section thickness, and staining protocols. Alcohol-based fixatives often obscure the nuclear detail with blurred chromatin and inconspicuous nucleoli (c) Whereas Hollandes fixative enhances nucleoli with visible nucleoli even in basal cells of benign glands
  • 43. 3: nuclear atypia – hyperchromasia. Compared to the adjacent benign glands, cancer cells can have larger hyperchromatic and pleomorphic nuclei (arrows)
  • 44. Minor features (less strongly associated with cancer, may also be seen in non cancer lesions)  Cytoplasm  Cytoplasmic amphophilia (dark cytoplasm)  Intraluminal contents  Amorphous secretion  Blue mucin  Crystalloids  Mitosis and apoptosis  More common in prostate cancer  Adjacent high-grade prostatic intraepithelial neoplasia (HGPIN)  Cancer often associated with HGPIN
  • 45. Amphophilic cytoplasm. • Compared with benign glands with clear cytoplasm, cancer glands often have amphophilic, or dark, cytoplasm. • This feature can be appreciated at low scanning power and, together with the infiltrative growth Pattern • Often provides the first clue to the presence of cancer in the biopsy. • The atypical glands with these minor features usually appear significantly different and therefore stand out from the benign glands
  • 46. Amorphous intraluminal secretion. • Cancer glands have eosinophilic amorphous material within their lumens. • They are more common in cancer, but can also be found in some benign lesions
  • 47. Blue mucin. • Cancer glands have blue-tinged wisps of mucin, often together with dense pink secretion, within their lumens. • They are more common in cancer, but can also be found in some benign lesions.
  • 48. Crystalloids. • Dense eosinophilic crystalloid structures that assume various shapes such as rhomboid and needle are in the lumens of the cancer glands. • They are more common in cancer, but can also be found in some benign lesions
  • 49. Mitosis and Apoptosis. A mitotic figure (arrow, a) and apoptotic bodies (arrows, b) are found in cancer glands.
  • 50. Cancer associated with HGPIN. 1. Cancer glands (arrowheads) often intermingle with HGPIN glands (arrows). 2. The presence of HGPIN should alert pathologists to look for cancer in the biopsy
  • 51. Benign Conditions That Cause Architectural and Cytological Atypia Benign process Atypical histological features Inflammation Small, crowded or cribriform glands Significant nucleoli Atrophy Haphazard and disorganized pattern, poorly formed glands, mild nuclear enlargement, and small nucleoli Adenosis (atypical adenomatous hyperplasia) Crowded glands HGPIN with adjacent small focus of atypical glands A few atypical glands immediately adjacent to larger HGPIN glands (uncertain whether atypical glands represent micro invasive cancer or tangential sectioning and/or outpouching of HGPIN glands)
  • 52. Benign prostate glands with exuberant inflammation. • The epithelial cells exhibit significant cytological atypia, including nuclear enlargement and small nucleoli. • Cancer glands, however, can also be associated with inflammation
  • 53. Simple atrophy. (a) Glands have lobulated architecture (b) Nuclei are slightly enlarged with small or inconspicuous nucleoli
  • 54. Adenosis. • Circumscribed, lobular collection of glands with variable sizes. • Some glands are clearly benign with large irregular contour and undulating luminal borders. • Smaller glands with rigid lumens are identical to larger benign glands cytologically
  • 55. HGPIN with adjacent small focus of atypical glands (PINATYP). • A few atypical glands (arrowhead) lie immediately adjacent to larger HGPIN glands (arrows) and are negative for basal cell marker p63 and positive for a methylacyl-CoA racemase (AMACR) • Note the HGPIN glands are also positive for AMACR and are scarcely positive for p63.
  • 56. Prostate cancer with subtle architectural and cytological atypia. (a) In this case, the cancer glands display crowded growth pattern (b) The cancer cells have minimum nuclear enlargement and inconspicuous nucleoli (c)This focus is negative for basal cell marker p63 .The cancer diagnosis in such cases requires a substantial number of cancer glands and IHC
  • 57. Histological Features For and Against Cancer Diagnosis in Biopsy
  • 58. Quantitative Threshold for Diagnosing Limited Cancer in Biopsy  Depending on the architectural and cytological atypia- more atypia, fewer glands are required to make a cancer diagnosis.  At least three glands are required to make a cancer diagnosis, if there is no full-blown cancer associated architectural and cytological features.
  • 59. A Practical Approach to Diagnosis of Limited Cancer in Needle Biopsy  Use benign glands as reference and evaluate the architectural and cytological features of atypical glands  A definitive cancer diagnosis can be established only when all three criteria are met: 1. Atypical glands exhibiting major and/or minor architectural atypia 2. Atypical glands exhibiting cytological atypia 3. Benign processes that may cause architectural and cytological atypia are carefully considered and ruled out.
  • 60. Limited prostate cancer. There are only five cancer glands present in one needle core. However, they display infiltrative growth pattern
  • 61. Limited prostate cancer. • Significant nuclear enlargement and hyperchromasia . • These atypical glands are not inflamed or atrophic. • These glands are negative for p63
  • 62.
  • 63. Benign mimics of prostatic carcinoma
  • 65. Seminal vesicle/ejaculatory duct epithelium. • At low power peripherally located well-formed small branching glands with cytoplasmic amphophilia, budding from central dilated lumina is a common feature. Well-formed muscular layer surrounding glands favors seminal vesicle tissue. • At higher magnification, the epithelium lining the lumina and small glands show nuclear hyperchromasia and random pleomorphism (arrows), also referred to as “monster nuclei.” • Nuclear pseudoinclusions are commonly seen. • Prominent golden-brown lipofuscin granules (arrowhead) are typical.
  • 66. Verumontanum mucosal gland hyperplasia. • At low power lobulated collection of relatively uniform, closely packed, round, small acini, frequently accompanied by adjacent urothelial epithelium (arrow) is a common presentation. • Intraluminal brown orange concretions (arrow) are a frequent and distinctive feature. • At high magnification The luminal cells have small uniform nuclei and inconspicuous nucleoli. An intact basal cell layer is present
  • 67. • Cowper’s glands. • Composed of tightly circumscribed or lobulated proliferation of small, uniform acini lined by mucus-containing cells with a central duct. • This dimorphic population of ducts (arrow) surrounded by acini is characteristic . Cytological features are bland, including small nuclei and inconspicuous nucleoli. • Mucin is present in the intracellular compartment in contrast to intraluminal mucin in prostate cancer • Skeletal muscle is frequently present in stroma
  • 68. Mesonephric remnant hyperplasia. • Glands appear atrophic with attenuated bland epithelium and grow in a lobulated or sometimes infiltrative pattern. • Intraluminal dense eosinophilic secretions (arrows) and papillary infoldings and tufts are common useful features to distinguish from adenocarcinoma of the prostate
  • 69. Mucinous metaplasia typically involves part of a lobule. 1. Transition to benign atrophic glands in the background is seen. 2. Glands are lined by tall columnar cells with abundant intracytoplasmic mucin. 3. In contrast to Cowper’s glands, dimorphic duct/acini architecture is not seen
  • 70. Simple atrophy, cystic atrophy a) In simple atrophy, overall architecture of the glands is maintained with marked reduction of cytoplasm, creating a basophilic appearance at low power b) In cystic atrophy, an undulated glandular architecture of the normal gland is lost; glands are round and cystically dilated with attenuated cytoplasm . c) Accompanied by inflammation and sclerotic stroma .
  • 71. Morphological spectrum of partial atrophy. The majority of partial atrophy lesions are composed of a lobular arrangement of crowded glands with stellate/undulating gland lumina, and scant pale clear cytoplasm, imparting a distinct pale appearance at low power .
  • 72. • Partial atrophy composed of a disorganized proliferation of predominantly small, round to occasionally poorly formed glands (arrows). • In addition to partially atrophic glands, there are several completely atrophic glands (arrowheads), a very useful diagnostic clue. • The pale cytoplasm of the lesion is similar to the adjacent benign gland • At high power, frequent micronucleoli (arrow) are visible. Note pale, clear cytoplasm placed laterally to the nuclei, lack of nuclear enlargement and macronucleoli, as well as the presence of few completely atrophic glands within the focus .
  • 73. • Partial atrophy showing disorganized growth pattern and predominant poorly formed glands mimicking cancer. • Note relatively benign cytology, pale cytoplasm, and few completely atrophic glands within the focus. • Immunohistochemistry for basal cell markers demonstrates very patchy staining with the lack of staining in the majority of glands
  • 74. Partial atrophy with atypical features, suspicious for cancer. 1. At low power, several disorganized glands with partially atrophic cytoplasm are present. A few completely atrophic glands are also present. These features are suggestive of partial atrophy. 2. At higher magnification, these glands demonstrated bland cytology. However,the edge of this lesion appears infiltrative (arrow, a) 3. IHC identical to cancer 4. Despite the presence of several features of partial atrophy, one cannot rule out cancer. Therefore, it is best to diagnose this case as atypical suspicious for cancer
  • 75. • Postatrophic hyperplasia. • At low power, circumscribed /lobulated collection of small dark atrophic acini with round-to-distorted contours arranged around a larger dilated duct (arrow; a b). • The dark appearance of the lesion at low power may arouse a suspicion for cancer but is due to scant cytoplasm rather than abundant amphophilic/granular cytoplasm seen in cancer.
  • 76.  At high magnification, the acini are lined by cuboidal secretory cells with minimal nuclear enlargement, increased nucleus-to- cytoplasmic ratio, and small but visible nucleoli. The stroma is usually sclerotic
  • 77. • Pseudoinfiltrative growth patterns in focal atrophy. (a–b) • Benign atrophic glands with haphazard or pseudoinfiltrative growth pattern may raise concern at low-power examination (a and b). • However, the pattern of infiltration is like a “patch” different than the true infiltration pattern with cancer glands situated between or on both sides of the benign glands
  • 78. Adenosis (atypical adenomatous hyperplasia). • a. At low power, adenosis is characterized by a circumscribed collection of variably sized glands • b. Within the nodule, small round acini are admixed with larger benign-appearing glands with papillary infolding (arrows). There are no obvious cytoplasmic or cytological differences between them. Essentially, small and large glands merge with each other imperceptibly.
  • 79. • c. At high power, the columnar cells have abundant pale to clear cytoplasm and bland-appearing nuclei with inconspicuous to small nucleoli . • d. The stroma between the glands is cellular, a feature to suggest a benign reactive nature .
  • 80. • (e)Basal cell markers typically demonstrate a discontinuous/patchy- staining pattern, with some glands lacking the staining . • (f)A small percentage (~30%) of adenosis lesions may demonstrate mild-to-moderate AMACR expression
  • 81. Basal cell hyperplasia. (a). A well-circumscribed nodule of basal cell hyperplasia, also referred to as basal cell adenoma is a form of epithelial hyperplasia in which glands have markedly stratified lining cells with high N:C ratio, and appears basophilic at low magnification (b).In incomplete basal cell hyperplasia, a luminal differentiation is Seen.
  • 82. (c) In complete basal cell hyperplasia, dark-staining nests are seen in a cellular stroma. • Note the lack of lumen formation. The presence of cellular spindly stroma is a feature suggestive of the benign proliferative nature • In basal cell hyperplasia, nuclei are stratified, arranged like a pack of cigar without visible cytoplasm and are coffee bean–like with frequent grooves and vesicular glassy chromatin. (d).Prominent nucleoli are frequently seen (arrows in d).
  • 83. Basal cell hyperplasia (e)can also present with adenoid cystic carcinoma-like cribriform architecture simulating cribriform carcinoma. • Also note cellular spindly stroma (f)Intraluminal calcifications and cytoplasmic hyaline globules can be seen in basal cell hyperplasia
  • 84. Basal cell hyperplasia in prostate needle biopsy. a) Dark-staining nests with stratified epithelium are seen in a haphazard pattern b) Nuclei are stratified with frequent prominent nucleoli c) Immunohistochemical markers for basal cell detection are helpful in difficult cases (c, p63)
  • 85. Diagnostic Approach to Prostate Basal Cell Lesions
  • 86. Nephrogenic adenoma. A classical nephrogenic adenoma with both papillary and underlying tubular components. (a) Polypoid or papillary component has edematous stroma without well- defined fibrovascular cores and lining epithelium is cuboidal and lacks stratification. • Underlying tubules are variably sized and mimic renal tubules. Note thickened eosinophilic basement membrane surrounding tubules (arrow), one of the characteristic features of nephrogenic adenoma (b) Prostatic urethra biopsy exhibits exclusively a tubular component, mimicking a prostate adenocarcinoma
  • 87. Nephrogenic adenoma • The tubules are lined by cuboidal hobnail epithelium. • Degenerative cytological atypia and features such as intraluminal blue mucin can be encountered. • Background inflammation and calcifications are common (c and d).
  • 88. • Nephrogenic adenoma (e) presenting predominantly with nested (f) signet ring cell like pattern. • These patterns may be mistaken for nested urothelial carcinoma and poorly differentiated prostate adenocarcinoma. • Hyalinized basement membrane surrounding glands (f) and superficial nature of the lesion (e) are useful features to suggest the diagnosis
  • 89. (g). Rarely, nephrogenic adenoma may present with prominent fibrous and myxoid component (h). Cytoplasmic AMACR expression is present in the vast majority of nephrogenic adenoma, (i)Nuclear transcription factors PAX- 2 or PAX-8 are expressed in nephrogenic adenoma and are helpful markers to support the diagnosis in difficult cases
  • 90. Central zone histology mimicking HGPIN. (a) Central zone histology is typically a mimicker of HGPIN; however, prominent cribriform architecture in some cases may mimic cancer. • In the central zone, glands are complex with frequent papillation and undulating architecture with pseudostratified lining epithelium • At low magnification, glands demonstrate distinct cytoplasmic eosinophilia (b). Roman bridges and cribriform architecture are common • In contrast to HGPIN, nuclei stream parallel to bridges in comparison to perpendicular orientation in HGPIN
  • 91. (c). The cytological atypia is seen in basal cells (arrow), a feature helpful to differentiate from HGPIN or cancer Before making a diagnosis of HGPIN or atypia in biopsies from the base area of the prostate, central zone histology should be ruled out
  • 92. Clear cell cribriform hyperplasia. • Clear cell cribriform hyperplasia represents a spectrum of benign prostate hyperplasia and therefore is typically encountered in the transition zone of the prostate. (a)There is a nodular proliferation of nonconfluent cribriform glands with clear to eosinophilic cytoplasm (b)The cells forming the central lumina are cuboidal to low columnar secretory-type cells, with uniform round nuclei and clear cytoplasm. • The glands (arrows) are rimmed with a prominent basal cell layer
  • 93.
  • 94. Malakoplakia. • There is a diffuse sheet-like proliferation of pink epithelioid histiocytes, accompanied by other inflammatory cells, similar to nonspecific xanthogranulomatous prostatitis. • The histiocytic nature of epithelioid cells and the presence of Michaelis-Gutmann bodies (arrow) suggest the diagnosis of malakoplakia
  • 95. Sclerosing adenosis mimicking high-grade prostate carcinoma. • This specimen demonstrates a proliferation of poorly formed and complex glands mimicking high-grade prostate carcinoma. • Lowpower recognition is a key. (a). It typically forms a well-circumscribed nodule of tightly packed glands (b). At high magnification, glands demonstrate complex proliferation, poorly formed glands with slit-like lumina, fused glands, and even single cells with signet ring cell-like features, mimicking high-grade cancer
  • 96. (c)Stroma surrounding the glands is cellular and hyalinized (arrows). (d)Prominent nucleoli, crystalloids, and blue mucin are common
  • 97. (e)Basal cells are highlighted with basal cell marker p63. (f) Basal cells undergo myoepithelial metaplasia and show coexpression of basal cell markers and S-100 and muscle-specific actin. • When one or more well-circumscribed cellular lesions mimicking high-grade prostate cancer are encountered in TURP or biopsies from the transition zone of the prostate, sclerosing adenosis should be ruled out
  • 98. Paraganglia mimicking high-grade prostate carcinoma and extraprostatic extension. (a)At low power, paraganglia consist of small, solid nests of cells with clear cytoplasm separated by a delicate vascular network, mimicking high-grade Gleason pattern 4 or 5 prostate carcinoma. • Its presence in adipose tissue , impart an impression of extraprostatic tumor extension. (b)At high power, the cells have clear to amphophilic, finely granular cytoplasm. Random cytological atypia may be seen and nuclei are often hyperchromatic, but nucleoli are inconspicuous.
  • 99. Recognition of the delicate vascular network pattern referred to as the “Zellballen” arrangement is an important clue. In difficult cases, positive neuroendocrine markers support the diagnosis (synaptophysin)
  • 100. • Xanthomatous infiltrate in prostate needle biopsy. (a) Xanthoma cells grow in a diffuse infiltrative pattern, mimicking poorly differentiated prostate carcinoma with foamy features . (b)Lack of any glandular differentiation and relatively bland nuclear features suggests the diagnosis of xanthomatous infiltrate • In small needle biopsysamples, a panel of immunohistochemical markers of histiocytic lineage (CD- 68) and pancytokeratin may be necessary to rule out carcinoma. • Presence of other inflammatory cells would support the diagnosis of xanthomatous infiltrate
  • 101. Commonly Used Immunohistochemical Markers for Diagnosis of Prostate Cancer in Biopsy
  • 102. Basal Cell Markers  Types of basal cell markers 1. HMWCK: cytoplasmic intermediate filaments detected by several antibody preparations (34bE12, CK5/6, CK14) 2. p63: nuclear antigen 3. Basal cell cocktail (34bE12+ p63)  Staining pattern in prostate cancer 1. Prostate carcinoma lacks staining for basal cell markers 2. HMWCK may rarely be positive in cancer cells, but not in basal cell distribution, due to excessive antigen retrieval and staining 3. p63 can rarely be found in cancer cells with uniform and non-basal cell distribution  Diagnostic utility  A negative basal cell marker staining in atypical glands morphologically suspicious for cancer supports a cancer diagnosis  Pitfalls  Adenosis, partial atrophy, high-grade prostatic intraepithelial neoplasia (HGPIN) may have discontinuous or even absent basal cell lining
  • 103. a-Methylacyl CoA Racemase (AMACR, P504S)  Types of antibodies  Monoclonal (P504S) and polyclonal, both with comparable sensitivity and specificity  Staining pattern in prostate cancer  Apical cytoplasmic granular staining  Diagnostic utility 1. Positive AMACR staining in atypical glands morphologically suspicious for cancer supports a cancer diagnosis 2. Positive AMACR may convert an ATYP to cancer diagnosis where morphology is suspicious for but not diagnostic of cancer and basal cell markers are negative
  • 104.
  • 105. Points to remember in Gleason Grading on needle biopsy  Gleason grade is solely based on architectural pattern, cytologic features are not factored in.  Both the primary (predominant) and secondary (second most prevalent) architectural patterns are identified and assigned a grade from 1 to 5, with 1 being the most differentiated and 5 being undifferentiated.  If a tumor has only one histologic pattern, then for uniformity, the primary and secondary patterns are given the same grade.  Full Gleason score is assigned to even to small foci of cancer on needle biopsy, because it has been demonstrated that the grade assigned to these minimal cancers is just as accurate compared with cases with more extensive cancer on biopsy.
  • 106.  In setting of three grades on biopsy where the highest grade is the least common, the highest grade is taken as the secondary pattern.  One should assign a separate Gleason score to each involved core, especially when one of the cores is high grade (Gleason score 4 + 4 = 8) and other cores have lower-grade cancer.
  • 107. Current Concepts of Gleason Grading 1. Gleason pattern 1 or 2 should be rarely if ever applied in the biopsy setting 2. Gleason grade in the biopsy setting essentially starts with Gleason pattern 3 3. A few malignant glands located between benign glands indicate pattern 3 (small focus of cancer does not necessarily mean low-grade cancer) 4. Virtually all cribriform carcinomas represent pattern 4 or 5 if associated with necrosis 5. Clusters of glands with poorly formed glandular lumina where tangential sectioning is ruled out represent Gleason pattern 4
  • 108. 6. Percentage of pattern 4 in the setting of Gleason score 7 (3 + 4 versus 4 + 3) bears prognostic importance 7. Multiple cores with cancer of different Gleason grades, grade information of individual core(s) better correlates with Gleason grade of radical prostatectomy 8. Any amount of higher pattern in the needle biopsy should be reported 9. In the setting of high-grade tumor of large volume, a small amount (< 5%) of lower-grade pattern can be ignored and need not be reported 10. Tertiary pattern 5 in the biopsy should be reported as the secondary pattern in the needle biopsy due to its prognostic significance 11. Many “special” types of prostate cancers are considered examples of Gleason pattern 4 or 5
  • 109. Future Trends in Prostate Biopsy Sampling and Its Clinical Applications
  • 110. References  Springers Prostate Biopsy Interpretation: An Illustrated Guide by Shah and Zhou.  Lippincotts Williams and Wilkins Prostate biopsy interpretation series by Epstein and Yang.  Robbins and Cotran pathologic basis of disease 9e.  Sternberg’s Diagnostic surgical pathology.

Editor's Notes

  1. In small biopsy samples, seminal vesicle and ejaculatory duct structures are usually not distinguishable unless biopsy targeting seminal vesicle is performed.